Skip to main content
Premium Trial:

Request an Annual Quote

DnaNudge Inks Distribution Deal for SARS-CoV-2 Test, Other Products in Spain

NEW YORK — UK diagnostics firm DnaNudge said on Tuesday that it has signed an exclusive distribution agreement for its PCR-based SARS-CoV-2 test and other genetic testing products in Spain with Quirónprevención.

Under the terms of the deal, Madrid-based Quirónprevención will offer DnaNudge's CovidNudge, a CE-IVD-marked point-of-care assay for SARS-CoV-2. Quirónprevención — a part of Spanish hospital group Quirónsalud — will also distribute DnaNudge's nutrition service, which uses an individual's genetic profile to make eating recommendations, and its upcoming skincare service.

Financial and other terms of the agreement were not disclosed.

Last month, DnaNudge raised $60 million in private financing.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.